Valproate During Pregnancy Increases Risk of Impaired Cognitive Development in Newborn (6.30.11)
Including valproate sodium (Depacon), divalproex sodium (Depakote, Depakote CP, and Depakote ER), valproic acid (Depakene and Stavzor), and their generics
To report complications resulting from Valproate:
- Complete and submit the report Online: MedWatch Online Voluntary Reporting Form (3500)
- Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178